A New Option for Therapeutic Management of Patients with Cerebrovascular Disease Massimo Volpe Editorial 22 January 2013 Pages: 105 - 107
β-Blockers and Diuretics in the Treatment of Hypertension Massimo Volpe Editorial 22 January 2013 Pages: 109 - 111
The Clinical Significance of Blood Pressure Lowering Treatment: First-Line Drug Choice is Important Luis M. Ruilope Current Opinion 22 January 2013 Pages: 113 - 115
The Clinical Significance of Blood Pressure Lowering Treatment: Is First-Line Drug Choice Important? Guido Grassi Current Opinion 22 January 2013 Pages: 117 - 119
Is Renin-Based Treatment a Reasonable Strategy to Treat Essential Hypertension? Andrea VerhovezPaolo MulateroFranco Veglio Review Article 22 January 2013 Pages: 121 - 125
Coronary Flow Reserve and Small Artery Remodelling in Hypertensive Patients Damiano RizzoniCarlo PalomboEnrico Agabiti Rosei Original Research Article 22 January 2013 Pages: 127 - 134
Is C-Reactive Protein a Reliable Risk Factor of Cardiovascular Morbidity and Mortality in Clinical Practice? Luigi VernaglioneViviana NosellaStefano Chimienti Original Research Article 22 January 2013 Pages: 135 - 139
Arterial Hypertension and Cardiac Damage Enrico Agabiti RoseiGiovanni de SimoneMassimo Volpe Guidelines 22 January 2013 Pages: 141 - 170
1.2 Comparison Between CRP and Other Conventional Risk Factors on Arterial Stiffness in Treated Essential Hypertension C. GiannattasioM. FaillaG. Mancia Contributions from International Congress 22 January 2013 Pages: 171 - 171
1.1 Platelet Activation and Cognitive Impairment in Elderly Patients with Metabolic Syndrome G. DesideriD. GrassiC. Ferri Contributions from International Congress 22 January 2013 Pages: 172 - 172
1.3 Renal Angioplasty Reduces Leukocytes Count in Hypertensive Patients with Atherosclerotic Renal Artery Stenosis A. MorgantiB. GidaroC. Lonati Contributions from International Congress 22 January 2013 Pages: 173 - 173
1.4 Manidipine Inhibits the Release of Interleukin-6 (Il-6) Induced by Modified Lipoprotein and by TNF-Alpha in Culture Human Endothelial Cells S. CostaM. PedrelliG. Cremonesi Contributions from International Congress 22 January 2013 Pages: 174 - 174
1.5 Brisighella Heart Study: Hypertension, HDL Cholesterol and Triglycerides S. D’AddatoE. TartagniC. Borghi Contributions from International Congress 22 January 2013 Pages: 175 - 175
1.6 Brisighella Heart Study (BHS): Hypertension and Lipidic Parameters S. D’AddatoA. DormiC. Borghi Contributions from International Congress 22 January 2013 Pages: 176 - 176
1.7 Carotid Intima-Media Thickness and Prevalence of Plaques in Patients with Primary Aldosteronism and With Essential Hypertension M. SalvettiM.L. MuiesanE. Agabiti-Rosei Contributions from International Congress 22 January 2013 Pages: 177 - 177
1.8 A Functional LDL Receptor-Related Protein 6 Gene Variant is an Independent Risk Factor For Early Carotid Artery Atherosclerosis in Hypertensive Patients R. SarzaniF. SalviA. Rappelli Contributions from International Congress 22 January 2013 Pages: 178 - 178
1.9 Circulating Vascular Endothelial Growth Factor and Cell Adhesion Molecule Levels are Increased In ‘Non-Dipper’ Patients I. De RomaR. RiaG. Ranieri Contributions from International Congress 22 January 2013 Pages: 179 - 179
1.10 Superiority of Apolipoproteins Compared to Non-HDL Cholesterol in Predicting the Presence of Coronary Disease in Hypertensive Patients with Ischemic Heart Disease F. PaneniS. SciarrettaM. Volpe Contributions from International Congress 22 January 2013 Pages: 180 - 180
1.11 Prevalence of Metabolic Alterations In Hypertensive Patients with Stable vs Unstable Angina F. PaneniS. SciarrettaM. Volpe Contributions from International Congress 22 January 2013 Pages: 181 - 181
1.12 C-Reactive Protein is Associated with Aortic Stiffness Independently of Microalbuminuria in Essential Hypertension G. Mule’S. CottoneG. Cerasola Contributions from International Congress 22 January 2013 Pages: 182 - 182
2.1 Blood Pressure Fall Overestimates the Association with the Vascular Damage, if not Adjusted for the Real Sleep Time P. NazzaroG. SchirosiF. Federico Contributions from International Congress 22 January 2013 Pages: 183 - 183
2.2 Reverse Dipping Blood Pressure Pattern is Characterized by a Marked Adrenergic Overdrive G. SeravalleR. Dell’OroG. Mancia Contributions from International Congress 22 January 2013 Pages: 184 - 184
2.3 New-Onset Diabetes Mellitus and Impaired Fasting Glucose in White Coat, Masked And Sustained Hypertension: the PAMELA Study M. BombelliH. Polo FrizG. Mancia Contributions from International Congress 22 January 2013 Pages: 185 - 185
2.4 White Coat and Masked Hypertension Increase the Risk of New Onset Sustained Hypertension in the General Population M. BombelliH. Polo FrizG. Mancia Contributions from International Congress 22 January 2013 Pages: 186 - 186
2.5 Correlation between Central Obesity and Nocturnal Hypertension in a female population M.C. BraviC. CapristoL. Gasbardone Contributions from International Congress 22 January 2013 Pages: 187 - 187
2.6 Proposal of a New Index and Criteria for Evaluation in Ambulatory Blood Pressure Monitoring G. MalgieriR. BattistaC. Santoro Contributions from International Congress 22 January 2013 Pages: 188 - 188
2.7 Ambulatory Arterial Stiffness Index and Cardiovascular Risk in a Sample of Hypertensive Adult Population L. D’EliaR. IppolitoF. Galletti Contributions from International Congress 22 January 2013 Pages: 189 - 189
2.8 In Patients with Isolated Ambulatory Hypertension Central Blood Pressure and Augmentation Index are Increased: the VOBARNO Study A. PainiML. MuiesanE. Agabiti-Rosei Contributions from International Congress 22 January 2013 Pages: 190 - 190
3.1 Genetics of Cardiovascular Risk in the Elderly: the ROVIGO study (Risk of Vascular Complication: Impact of Genetics in Old People) A. MazzaS. ZamboniS. Cuppini Contributions from International Congress 22 January 2013 Pages: 191 - 191
3.2 Cardiometabolic Prevention Project (PRECAM) in a Tuscany Population S. LentiP. BorgheresiStudy Group PRECAM Contributions from International Congress 22 January 2013 Pages: 192 - 192
3.3 Role of a Specialist Hospital Centre In Hypertensive Patients Risk Stratification M. CrippaS. EttoriR. Fariello Contributions from International Congress 22 January 2013 Pages: 193 - 193
3.4 Fat Distribution and Cardiovascular Risk in Obese Women G. SalvettiF. SantiniA. Salvetti Contributions from International Congress 22 January 2013 Pages: 194 - 194
3.5 Prevalence of Hypertension and Urinary Abnormalities in an Indian Paediatric Population A. AielloM. GallieniS. Genovesi Contributions from International Congress 22 January 2013 Pages: 195 - 195
3.6 Sodium Intake in a Sample of Males Working in Campania: Results of the Olivetti Heart Study A. VeneziaG. BarbaP. Strazzullo Contributions from International Congress 22 January 2013 Pages: 196 - 196
3.7 Hypertension and Impaired Carbohydrate Tolerance E. ColliR. PedrazzoliE. Bartoli Contributions from International Congress 22 January 2013 Pages: 197 - 197
3.8 Consensus Document on Diagnosis and Clinical Management of Obstructive Sleep Apnoea in Hypertensive Patients C. LombardiG. ManciaG. Parati Contributions from International Congress 22 January 2013 Pages: 198 - 198
3.9 Point of Care Testing of Cholesterol and Triglycerides In Epidemiological Studies: Evaluation of the MultiCare System S. RapiV. SbolciP.A. Modesti Contributions from International Congress 22 January 2013 Pages: 199 - 199
3.10 Assessment of Pulse Wave Velocity and Cardiovascular Risk Stratification in a General Population: the Vobarno Study M. SalvettiML. MuiesanE. Agabiti-Rosei Contributions from International Congress 22 January 2013 Pages: 200 - 200
3.11 Daily Activities in Hypertensive Elderly People Affected by Diabetes Mellitus Type II F. D’Amico Contributions from International Congress 22 January 2013 Pages: 201 - 201
3.12 Angiotensin II Receptor Blockers and Risk of Myocardial Infarction: a Meta-Analysis of Randomized Clinical Trials Updated Until May 1, 2008 M. VolpeG. TocciG. Mancia Contributions from International Congress 22 January 2013 Pages: 202 - 202
4.1 The B Allele of the BsmI Vitamin D Receptor (VDR) Gene Polymorphism is Independently Associated to LVH and to Higher Progression Rate of LVH in End-Stage Renal Disease (ESRD) Patients A. TestaF. MallamaciC. Zoccali Contributions from International Congress 22 January 2013 Pages: 203 - 203
4.2 Chromosome 2q12: the Adrenergic Receptor 2b (ADRA2b) Gene and Metabolic Syndrome in Swedish — is there a Link? C. FavaM. MontagnanaO. Melander Contributions from International Congress 22 January 2013 Pages: 204 - 204
4.3 The V433M Variant of the CYP4F2 is Associated with Ischemic Stroke in Male Swedish Beyond its Effect on Blood Pressure C. FavaM. MontagnanaO. Melander Contributions from International Congress 22 January 2013 Pages: 205 - 205
4.4 Correlation Between NCX1 Polymorphisms and Therapy-Resistant Essential Hypertension V. TrimarcoR. GiudiceN. De Luca Contributions from International Congress 22 January 2013 Pages: 206 - 206
4.5 Linkage of Familial Hyperaldosteronism Type II at Chromosome 7p22 in Two Italian Families P. MulateroN. SukorM. Stowasser Contributions from International Congress 22 January 2013 Pages: 207 - 207
4.6 Angiotensinogen Promoter Variants and Tissue-Specific Regulation of Angiotensinogen Expression in Human Kidney and Visceral Adipose Tissue R. SarzaniM. BordicchiaA. Rappelli Contributions from International Congress 22 January 2013 Pages: 208 - 208
4.7 Heritability of Plasma Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): a New Marker of Cardiovascular Risk L. LenziniB. CarocciaG. Rossi Contributions from International Congress 22 January 2013 Pages: 209 - 209
5.1 Cardiac Natriuretic Peptides Reflect Left Atrial Volume (LAV) and Capture Longitudinal Changes in LAV in End-Stage Renal Disease Patients G. TripepiF.A. BenedettoC. Zoccali Contributions from International Congress 22 January 2013 Pages: 210 - 210
5.2 Myocardial Integrated Backscatter in Normotensive and Hypertensive Diabetic Patients A.C.M. CapraC. GiannattasioG. Mancia Contributions from International Congress 22 January 2013 Pages: 211 - 211
5.3 Left Ventricular Mass Independently Contributes to Long-Term Risk of Cardiovascular Morbidity and Mortality in a General Population: Data From the PAMELA Study M. BombelliR. SanvitoG. Mancia Contributions from International Congress 22 January 2013 Pages: 212 - 212